Insider · CIK 0001424204
Michael P Stansky
Files at TLSI (TriSalus Life Sciences, Inc.). First filing Feb 23, 2026, latest May 18, 2026.
In brief
Michael P Stansky files SEC Form 4 as director at TLSI (TriSalus Life Sciences, Inc.). Since Feb 23, 2026, Michael P Stansky has reported 2 open-market buys worth $3.0M and 0 open-market sells worth $0, the latest filed on May 18, 2026.
A track record needs three past buys with six months of prices behind them; Michael P Stansky has 1, so none is measured yet.
The newest scored trade: bought $1.5M of TLSI on May 15, 2026, filed May 18, 2026, scored 88 (strong). In the last 12 months: 2 buys worth $3.0M and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
TLSI: TriSalus Life Sciences, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 88Strong | TriSalus Life Sciences, Inc. | $1.5M 610,000 shares | +73% | +6% from low-64% from high | |
| 73Notable | TriSalus Life Sciences, Inc. | $1.5M 361,098 shares | +66% | +40% from low-33% from high |
Transactions
Every row this insider has filed, 8 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 15, 2026 | TLSI TriSalus Life Sciences, Inc. | POpen-market purchase Common Stock | +410,000 | $2.50 | $1.0M | 1,240,722 | May 18, 2026 |
| May 15, 2026 | TLSI TriSalus Life Sciences, Inc. | POpen-market purchase Common Stockindirect: By Skyview Investments LLC | +200,000 | $2.50 | $500k | 399,698 | May 18, 2026 |
| May 14, 2026 | TLSI TriSalus Life Sciences, Inc. | AGrant or award Common Stock | +23,501 | $0.00 | $0 | 810,633 | May 15, 2026 |
| May 14, 2026 | TLSI TriSalus Life Sciences, Inc. | AGrant or award Common Stock | +20,089 | $0.00 | $0 | 830,722 | May 15, 2026 |
| May 14, 2026 | TLSI TriSalus Life Sciences, Inc. | AGrant or award Director Stock Option (right to buy)derivative | +47,003 | $0.00 | $0 | 139,540 | May 15, 2026 |
| Feb 23, 2026 | TLSI TriSalus Life Sciences, Inc. | POpen-market purchase Common Stock | +243,900 | $4.10 | $1000k | 787,132 | Feb 23, 2026 |
| Feb 23, 2026 | TLSI TriSalus Life Sciences, Inc. | POpen-market purchase Common Stockindirect: By LLC | +117,198 | $4.10 | $481k | 199,698 | Feb 23, 2026 |
| Feb 4, 2026 | TLSI TriSalus Life Sciences, Inc. | AGrant or award Director Stock Option (right to buy)derivative | +92,537 | $0.00 | $0 | 92,537 | Feb 11, 2026 |
Questions about Michael P Stansky
Answered from the filings on this page, as of the latest one.
Is Michael P Stansky buying or selling?
In the last 12 months Michael P Stansky reported 2 open-market buys worth $3.0M and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $1.5M of TLSI on May 15, 2026. Grants, option exercises and tax withholding are not counted.
How did Michael P Stansky's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Michael P Stansky has 1.
Where does Michael P Stansky file Form 4?
Michael P Stansky has filed Form 4 at TLSI (TriSalus Life Sciences, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.